Methods and materials for treating autoimmune diseases and conditions
AssigneeBoard of Regents, The University of Texas System
InventorsPremkumar Christadoss, Erdem Tuzun
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for treating an autoimmune disease or condition in a subject. The methods include administering to the subject a compound which inhibits the subject's classical complement pathway. Also disclosed are methods for suppressing hyperacute graft rejection in a subject. The methods include administering to the subject a compound which inhibits the subject's classical complement pathway. Compositions which include a specific inhibitor of C1q and a pharmaceutically acceptable excipient are also described.
Claims1
A method for treating myasthenia gravis in a subject, said method comprising:
- administering to the subject an anti-C1q antibody which inhibits the subject's classical complement pathway, wherein said anti-C1q antibody is a monoclonal antibody or chimeric humanized antibody thereof that binds C1q.
Dependencies are inferred from the claim text.